|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016701,
umls-concept:C0031928,
umls-concept:C0032893,
umls-concept:C0205210,
umls-concept:C0242415,
umls-concept:C0332152,
umls-concept:C0332173,
umls-concept:C0443224,
umls-concept:C0475358,
umls-concept:C0752248
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-4-14
|
|
pubmed:abstractText |
The 70-gene prognosis-signature is a prognostic tool for early breast cancer analysis. In addition to scientific evidence, implementation of the signature in clinical trials and daily practice requires logistical feasibility. The aim of our study was to test logistics for gene expression profiling on fresh frozen tumour tissue in the preparation for the prospective, multinational Microarray In Node-negative Disease may Avoid ChemoTherapy (MINDACT) trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1879-0852
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1201-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19232484-Aged,
pubmed-meshheading:19232484-Breast Neoplasms,
pubmed-meshheading:19232484-Carcinoma, Ductal, Breast,
pubmed-meshheading:19232484-Clinical Trials as Topic,
pubmed-meshheading:19232484-Cryopreservation,
pubmed-meshheading:19232484-Europe,
pubmed-meshheading:19232484-Feasibility Studies,
pubmed-meshheading:19232484-Female,
pubmed-meshheading:19232484-Gene Expression Profiling,
pubmed-meshheading:19232484-Humans,
pubmed-meshheading:19232484-Logistic Models,
pubmed-meshheading:19232484-Middle Aged,
pubmed-meshheading:19232484-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:19232484-Pilot Projects,
pubmed-meshheading:19232484-Specimen Handling,
pubmed-meshheading:19232484-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.
|
|
pubmed:affiliation |
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Division of Pathology and Surgical Oncology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
